Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Long-Term Debt Repayments (2016 - 2023)

Historic Long-Term Debt Repayments for Kyntra Bio (KYNB) over the last 9 years, with Q4 2023 value amounting to $34000.0.

  • Kyntra Bio's Long-Term Debt Repayments fell 6633.66% to $34000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $34000.0, marking a year-over-year decrease of 9156.33%. This contributed to the annual value of $336000.0 for FY2023, which is 1662.53% down from last year.
  • According to the latest figures from Q4 2023, Kyntra Bio's Long-Term Debt Repayments is $34000.0, which was down 6633.66% from $101000.0 recorded in Q3 2023.
  • In the past 5 years, Kyntra Bio's Long-Term Debt Repayments ranged from a high of $101000.0 in Q1 2019 and a low of $34000.0 during Q4 2023
  • Over the past 5 years, Kyntra Bio's median Long-Term Debt Repayments value was $101000.0 (recorded in 2019), while the average stood at $97400.0.
  • As far as peak fluctuations go, Kyntra Bio's Long-Term Debt Repayments soared by 100.0% in 2019, and later tumbled by 6633.66% in 2023.
  • Kyntra Bio's Long-Term Debt Repayments (Quarter) stood at $101000.0 in 2019, then changed by 0.0% to $101000.0 in 2020, then changed by 0.0% to $101000.0 in 2021, then changed by 0.0% to $101000.0 in 2022, then tumbled by 66.34% to $34000.0 in 2023.
  • Its Long-Term Debt Repayments stands at $34000.0 for Q4 2023, versus $101000.0 for Q3 2023 and $100000.0 for Q2 2023.